Centhaquin
Centhaquine (Centhaquin; PMZ-2010) is a novel agent has the potential for treatment of haemorrhagic shock. Centhaquine (Centhaquin; PMZ-2010) can augment cardiac output, reduce systemic vascular resistance in haemorrhagic models[1][2].
Product Specifications
CAS Number
57961-90-7
Product Name Alternative
Centhaquine; PMZ-2010
UNSPSC
12352005
Hazard Statement
H315, H319, H413
Target
Others
Type
Reference compound
Related Pathways
Others
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/centhaquin.html
Purity
99.93
Solubility
DMSO : 62.5 mg/mL (ultrasonic)
Smiles
CC1=CC=CC(N(CC2)CCN2CCC3=NC4=C(C=CC=C4)C=C3)=C1
Molecular Formula
C22H25N3
Molecular Weight
331.45
Precautions
H315, H319, H413
References & Citations
[1]Srimal RC, et al. Pharmacological studies on 2- (2- (4- (3-methylphenyl) -1-piperazinyl) ethyl) quinoline (centhaquin) . I. Hypotensive activity.Pharmacol Res. 1990 May-Jun;22 (3) :319-29.|[2]Papalexopoulou K, et al. Centhaquin Effects in a Swine Model of Ventricular Fibrillation: Centhaquin and Cardiac Arrest.Heart Lung Circ. 2017 Aug;26 (8) :856-863.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 4
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K1012204 1.0 µg DNA
ICT1 sgRNA CRISPR Lentivector (Human) (Target 3)
Sign In for Pricing
View Details 